Skip to content

C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting

Efficacy of Point-of-care (POC) C-reactive Protein Testing to Reduce Inappropriate Use of Antibiotics for Acute Respiratory Infections (ARIs) in the Primary Health Care Setting of Hanoi - a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01918579
Acronym
CRP
Enrollment
2037
Registered
2013-08-07
Start date
2014-03-31
Completion date
2015-09-30
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infections

Brief summary

Many studies have showed that rapid point-of-care (POC) c-reactive protein (CRP) test can reduce inappropriate use of antibiotic at primary health care level. In Vietnam, prevalence of antibiotic abuse for community acute respiratory infection has been reported. This study will test the hypothesis that CRP POC testing for patients with non-severe acute respiratory illness at primary healthcare stations reduces inappropriate antibiotic use safely. The study will be conducted at ten district health care facilities in Hanoi, Viet Nam. Investigators intend to enroll 2,000 participants aged 6-65 years with non-severe acute respiratory infection. Patients will be randomly allocated to the control or the intervention arm. Participants in the control group will be treated according to routine care. Participants in the intervention arm will have a CRP test, the results of which will be available to the health care practitioner to contribute to their diagnosis and treatment decisions. All patients will be followed-up via telephone call after 14 days. The study will compare the proportion of patients in each arm receiving any antibiotics within 2 weeks of study enrollment.

Interventions

PROCEDUREPatients will be tested by rapid POC CRP test

Patient will be tested with CRP test. Treatment decisions including any antibiotics prescribed will be based on test results and clinical judgement. Treatment choices are not recommended/prescribed by the study protocol.

Sponsors

National Hospital for Tropical Diseases, Hanoi, Vietnam
CollaboratorOTHER_GOV
Oxford University Clinical Research Unit, Vietnam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients, aged 6 to 65 years, that visit one of the 10 selected primary healthcare centers * Suspected to have acute respiratory tract infection (ARI) by treating physician * Informed consent

Exclusion criteria

* Severe respiratory disease as determined by treating doctor * Any disease or symptom requiring hospital referral as determined by treating doctor * Immunosuppressed patients (e.g. HIV, long term steroid use) * Suspicion of tuberculosis * Evidence of acute or chronic liver disease (e.g. hepatitis or cirrhosis due to any cause) * Past medical history of: neoplastic disease, congestive cardiac failure, chronic obstructive pulmonary disease, insulin-dependent diabetes or renal disease * Pregnancy * No access to telephone * Not able to come for follow up visit on day 3 or 4. * Already taking antibiotics at the time of presentation * Symptoms present for more than 2 weeks * Presence of any sign of severe diseases as defined by the British Thoracic Society modified CRP-65 system for severity scoring of pneumonia in primary care. For children (Age ≥ 6 years and \< 16 years) additional

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients receiving any antibiotic2 weeksNumber of patients receiving any antibiotic within 2 weeks of study enrollment as a proportion of the total number of patients.

Secondary

MeasureTime frameDescription
Frequency of serious adverse events2 weeksNumber of serious adverse events which occur during the 14 day follow-up period.
Duration of symptoms2 weeksNumber of days that symptoms (including fever or any respiratory symptom) endure.
Frequency of re-consultation2 weeksNumber of visits to a health care practitioner during the 14 day follow-up.

Other

MeasureTime frameDescription
The attitudes and satisfaction of patients and health center staff towards the test.2 weeksPatients and health center staff will be interviewed by structured questionnaire to assess their attitudes and satisfaction toward the intervention. The Likert scale will be used for quantifying attitude orientation of interviewees

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026